Michael Limbert
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
-
- Antibiotic Resistance in Bacteria 19
- Pharmacology 29
- Antibiotics Pharmacokinetics and Efficacy 24
- Microbial Natural Products and Biosynthesis 5
- Co-authors
- Gerhard Seibert (28 shared papers)NORBERT KLESEL (23 shared papers)E. Schrinner (23 shared papers)Irvin Winkler (9 shared papers)A. Markus (10 shared papers)Karlheinz Seeger (3 shared papers)Ulrich Hadding (5 shared papers)D Bitter-Suermann (5 shared papers)
- Journals
- The Journal of Antibiotics (16 papers)Journal of Antimicrobial Chemotherapy (5 papers)Infection (4 papers)Tetrahedron (3 papers)The Journal of Immunology (3 papers)
- Partner nations
- GermanyFranceSwitzerland
In The Last Decade
Michael Limbert
39 papers receiving 691 citations
Peers
Comparison fields: 5 of 86
- Molecular Medicine 271
- Pharmacology 438
- Microbiology 97
- Clinical Biochemistry 62
- Applied Microbiology and Biotechnology 14
Countries citing papers authored by Michael Limbert
This map shows the geographic impact of Michael Limbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Limbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Limbert more than expected).
Fields of papers citing papers by Michael Limbert
This network shows the impact of papers produced by Michael Limbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Limbert. The network helps show where Michael Limbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Limbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 124 | |
| 2 | 1991 | 98 | |
| 3 | 1983 | 47 | |
| 4 | 1983 | 45 | |
| 5 | 1980 | 43 | |
| 6 | 1973 | 37 | |
| 7 | 1984 | 32 | |
| 8 | 1975 | 29 | |
| 9 | 1974 | 27 | |
| 10 | 1992 | 26 | |
| 11 | 1993 | 25 | |
| 12 | 1995 | 25 | |
| 13 | 1984 | 24 | |
| 14 | 1984 | 23 | |
| 15 | 1984 | 23 | |
| 16 | 1994 | 22 | |
| 17 | 1982 | 21 | |
| 18 | 1987 | 19 | |
| 19 | 1974 | 17 | |
| 20 | 1992 | 17 |
About Michael Limbert
Michael Limbert is a scholar working on Molecular Medicine, Pharmacology, Microbiology, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 41 papers that have together received 848 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Antibiotic Resistance in Bacteria (19 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers), Microbial Natural Products and Biosynthesis (5 papers), Complement system in diseases (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Molecular Medicine (271 citations), Pharmacology (438 citations), Microbiology (97 citations), Clinical Biochemistry (62 citations) and Applied Microbiology and Biotechnology (14 citations). Michael Limbert has collaborated with scholars based in Germany, France and Switzerland. Frequent co-authors include Gerhard Seibert, NORBERT KLESEL, E. Schrinner, Irvin Winkler, A. Markus, Karlheinz Seeger, Ulrich Hadding, D Bitter-Suermann, Jürgen Blumbach and Rajendrakumar H. Jani. Their work appears in journals such as The Journal of Antibiotics, Journal of Antimicrobial Chemotherapy, Infection, Tetrahedron and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.